![DermConsult](https://i1.feedspot.com/5606706.jpg?t=1687514518)
DermConsult
180 FOLLOWERS
There's a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions and the practice of dermatology itself as "more than skin deep," turn to DermConsult. Here dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They..
DermConsult
1M ago
Guest: Andres Yarur, MD
It’s not uncommon for patients with inflammatory bowel disease (IBD) to have an overlapping immune-mediated condition like psoriasis, which is why it’s important to tailor therapy for these patients. Here to discuss the link between psoriasis and IBD and how this can affect our management approach is Dr. Andres Yarur, Associate Professor of Medicine at Cedars Sinai Medical Center in Los Angeles, California ..read more
DermConsult
1M ago
Guest: Shari Lipner, MD
A recent study was conducted looking at initial therapies for newly diagnosed psoriasis patients by race. Prior studies have shown differences by race in terms of emerging treatments for different dermatological diseases, which have also shown differential biologic treatments based on race. To learn about the findings and how we can help fill this gap, join Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine and co-author of the article, titled Racial Disparities in Primary Therapy for Newly Diagnosed Psoriasis Patients, which was pub ..read more
DermConsult
1M ago
Host: Matthew S. Keller MD
Host: Monica Schwartzman, MD, MS
Getting the proper treatment for patients with psoriasis and psoriatic arthritis can be life-changing. So how can clinicians help patients find the right medication? To discuss this topic together, Dr. Matthew Keller is joined by fellow ReachMD host, Dr. Monica Schwartzman, who is also a Rheumatologist ..read more
DermConsult
7M ago
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Neda Shahriari, MD
This study assessed the link between depressive symptoms in real-world patients with psoriasis to help identify characteristics for those at risk. What were the findings? To learn more, join Dr. Charles Turck as he speaks with Dr. Neda Shahriari, Board-Certified Dermatologist at Brigham and Women’s Hospital in Boston, Massachusetts ..read more
DermConsult
8M ago
Host: Raj Chovatiya, MD, PhD
Guest: Steven R. Feldman, MD, PhD
To gain a better understanding of the different treatment attributes that patients with moderate-to-severe atopic dermatitis value most, a discrete choice experiment was conducted. And now, the results are in, with itch control being the top attribute. Joining Dr. Raj Chovatiya to share this and other key findings from his research that was featured as a poster at the 2023 Fall Clinical Dermatology conference is Dr. Steven Feldman, Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University ..read more
DermConsult
8M ago
Host: Raj Chovatiya, MD, PhD
Guest: Melinda Gooderham, MSc, MD, FRCPC
Due to the evolving treatment landscape, the way we think about treating adult and elderly patients with atopic dermatitis has shifted. So what are some special considerations we need to think about when selecting a treatment option for long-term control, and how can we best involve patients in the decision-making process? Joining Dr. Raj Chovatiya to help answer these and other key questions in atopic dermatitis care is Dr. Melinda Gooderham, Medical Director for the SKiN Center for Dermatology in Peterborough, Ontario ..read more
DermConsult
8M ago
Host: Charles Turck, PharmD, BCPS, BCCCP
Guest: Linda Stein Gold, MD
This study enrolled adult patients who had moderate plaque psoriasis and who had a body surface area between 10 and 15 percent, a physician’s global assessment of a three, or moderate, and a PASI score of 12 or above. Dive in to learn more with Dr. Charles Turck as he speaks with Dr. Linda Stein Gold, Director of Clinical Research in the Department of Dermatology at Henry Ford Health in Detroit ..read more
DermConsult
11M ago
Host: Raj Chovatiya, MD, PhD
Guest: Steven R. Feldman, MD, PhD
The biologics we know are revolutionary treatments for our patients with psoriasis and now other inflammatory skin diseases. So how do biosimilars play a part in the evolving treatment of psoriasis? Learn more with Dr. Raj Chovatiya as he dives further into biosimilars with Dr. Steve Feldman, Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University School of Medicine in Winston-Salem, North Carolina ..read more
DermConsult
11M ago
Host: Raj Chovatiya MD, PhD
Guest: George Han, MD, PhD
The discovery of the IL-23 pathway has revolutionized the treatment of psoriasis. Learn more about the current state of IL-23 inhibition in psoriasis management with Dr. Raj Chovatiya and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale, New York ..read more
DermConsult
11M ago
Host: Raj Chovatiya MD, PhD
Guest: Matthew Zirwas, MD
Guest: Douglas DiRuggiero, DMSc, PA-C
When managing atopic dermatitis, it’s up to the patient to determine how much therapeutic intervention they want to pursue, which underscores the importance of applying shared decision-making to practice. Joining Dr. Raj Chovatiya to share their perspectives on how we can utilize shared decision-making in atopic dermatitis care are Dr. Matthew Zirwas and Mr. Douglas DiRuggiero. Dr. Zirwas founded Bexley Dermatology Research Clinic in Columbus, Ohio where he specializes in adult eczema, and Mr. DiRuggier ..read more